Advertisement

Topics

Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea

2010-07-15 17:00:00 | BioPortfolio

Summary

The purpose of this study is to determine whether NPC-01 is effective in the treatment of dysmenorrhea.

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Conditions

Dysmenorrhea

Intervention

NPC-01

Status

Not yet recruiting

Source

Nobelpharma

Results (where available)

View Results

Links

Published on BioPortfolio: 2010-07-15T17:00:00-0400

Clinical Trials [63 Associated Clinical Trials listed on BioPortfolio]

Randomized Controlled Trial of Acupuncture for Dysmenorrhea

Since there is unsatisfactory effect by currently pharmacologic therapies and preventive strategies for dysmenorrhea, this study is designed to evaluate the efficacy and quality of life of...

Pulse Diagnoses in Patients While Dysmenorrhea is Attacking

The mechanism led to the dysmenorrhea can be understood more clearly and one may have a better idea to treat the disease in the future.

Intravenous Tramadol Versus Intravenous Paracetamol in Patients With Dysmenorrhea

Patients presented with primary dysmenorrhea composed the study population. One gram paracetamol and 100 mg tramadol in 100 ml saline with a slow infusion were compared in ceasing dysmenor...

Effects of Combined Exercises on Primary Dysmenorrhea

Dysmenorrhea is one of the most common gynecological problem in adolescents and young women. Symptoms of dysmenorrhea include pelvic / abdominal pain, back pain, headache, nausea, vomiting...

The Efficacy of Viburnum Opulus 3X in the Treatment of Primary Dysmenorrhea

Dysmenorrhea (painful menstruation) is a common gynaecological disorder that is prevalent in more than 50% of women during their reproductive years. Primary dysmenorrhea describes cyclic u...

PubMed Articles [32 Associated PubMed Articles listed on BioPortfolio]

Somatic symptoms in women with dysmenorrhea and noncyclic pelvic pain.

Somatic symptoms are a robust, transdiagnostic risk factor for pain conditions. However, the extent to which somatic symptoms contribute to the manifestation of the women's pain syndromes, such as dys...

Identification of experimental bladder sensitivity among dysmenorrhea sufferers.

Dysmenorrhea is a common risk factor for chronic pain conditions including bladder pain syndrome. Few studies have formally evaluated asymptomatic bladder pain sensitivity in dysmenorrhea, and whether...

Analysis of characteristics and influence factors of diagnostic delay of endometriosis.

To access the influence factors of diagnostic delay of endometriosis.We designed a questionnaire of diagnostic delay of endometriosis. From February 2014 to February 2016, 400 patients who had dysmeno...

Pharmacokinetic-pharmacodynamic modeling to study the anti-dysmenorrhea effect of Guizhi Fuling capsule on primary dysmenorrhea rats.

Primary dysmenorrhea (PDM) is one of the most common gynaecological disorders among women, which seriously affects women's life quality due to its high incidence rate. Guizhi Fuling capsule (GZFLC), a...

Behavioral and neural responses to aversive visceral stimuli in women with primary dysmenorrhea.

Chronic pelvic pain, in particular dysmenorrhea, is a significant yet unresolved healthcare problem in gynecology. As interoceptive sensitivity and underlying neural mechanisms remain incompletely und...

Medical and Biotech [MESH] Definitions

Painful menstruation.

An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.

A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.

More From BioPortfolio on "Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial